The Discounted Cash Flow (DCF) valuation of Harpoon Therapeutics Inc (HARP) is (166.91) USD. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on DCF is -825.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.6% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (541.77) - (100.86) | (166.91) |
| Upside | -2454.5% - -538.3% | -825.4% |